NCT00000801View on ClinicalTrials.gov

Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 1998

Conditions

Lymphoma, Non-HodgkinHIV Infections

Interventions

DRUG

Filgrastim

DRUG

Vincristine sulfate

DRUG

Doxorubicin hydrochloride

DRUG

Cyclophosphamide

DRUG

Cytarabine

DRUG

Dexamethasone

Trial Locations (7)

10029

Mount Sinai Med Ctr, New York

29169

Julio Arroyo, West Columbia

80262

Univ of Colorado Health Sciences Ctr, Denver

941102859

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco

San Francisco Gen Hosp, San Francisco

02215

Beth Israel Deaconess - West Campus, Boston

02146

ECOG Data Management Office, Brookline

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000801 - Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma | Biotech Hunter | Biotech Hunter